Literature DB >> 24211530

Gene expressions changes in bronchial epithelial cells: markers for respiratory sensitizers and exploration of the NRF2 pathway.

Sylvie Remy1, Sandra Verstraelen2, Rosette Van Den Heuvel3, Inge Nelissen4, Nathalie Lambrechts5, Jef Hooyberghs6, Greet Schoeters7.   

Abstract

For the classification of respiratory sensitizing chemicals, no validated in vivo nor in vitro tests are currently available. In this study, we evaluated whether respiratory sensitizers trigger specific signals in human bronchial epithelial (BEAS-2B) cells at the level of the transcriptome. The cells were exposed during 6, 10, and 24h to 4 respiratory sensitizers and 6 non-respiratory sensitizers (3 skin sensitizers and 3 respiratory irritants) at a concentration inducing 20% cell viability loss after 24h. Changes in gene expression were evaluated using Agilent Whole Human Genome 4×44K oligonucleotide arrays. A limited number of 11 transcripts could be identified as potential biomarkers to identify respiratory sensitizers. Three of these transcripts are associated to immune system processes (HSPA5, UPP1, and SEPRINE1). In addition, the transcriptome was screened for transcripts that are differentially expressed compared to vehicle control for each chemical. The results show that the NRF2-mediated oxidative stress response is activated in the cell line after stimulation with all of the chemicals that were selected in our study, and that - at the level of gene expression - this pathway shows no potential to discriminate between any of the three compound groups: respiratory sensitizers, skin sensitizers, or electrophilic respiratory irritants.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BEAS-2B cell line; Gene expression markers; In vitro; Respiratory sensitization; Transcriptomics

Mesh:

Substances:

Year:  2013        PMID: 24211530     DOI: 10.1016/j.tiv.2013.10.017

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma.

Authors:  Yukui Gao; Guixin Wang; Yanzhuo Chen; Mingpeng Zhang; Wenlong Gao; Zhiqun Shang; Yuanjie Niu
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

2.  A new cytometry-based method reveals an accumulation of Nrf2 in dendritic cells exposed to two respiratory sensitizers.

Authors:  Adrien Audry; Julianne Mathiot; Samuel Muller; Amélie Coiscaud; Isabelle Langonné; Fabrice Battais; Brigitte Leininger; Isabelle Sponne
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

3.  5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers.

Authors:  Yiqing Zhao; Xiujing Feng; Yicheng Chen; J Eva Selfridge; Shashank Gorityala; Zhanwen Du; Janet M Wang; Yujun Hao; Gino Cioffi; Ronald A Conlon; Jill S Barnholtz-Sloan; Joel Saltzman; Smitha S Krishnamurthi; Shaveta Vinayak; Martina Veigl; Yan Xu; David L Bajor; Sanford D Markowitz; Neal J Meropol; Jennifer R Eads; Zhenghe Wang
Journal:  Cancer Res       Date:  2020-09-09       Impact factor: 13.312

4.  Uridine phosphorylase 1 is a novel immune-related target and predicts worse survival in brain glioma.

Authors:  Jin Wang; Shihai Xu; Wen Lv; Fei Shi; Shanshan Mei; Aijun Shan; Jianzhong Xu; Ying Yang
Journal:  Cancer Med       Date:  2020-06-24       Impact factor: 4.452

5.  Revealing potential diagnostic gene biomarkers of septic shock based on machine learning analysis.

Authors:  Yonghua Fan; Qiufeng Han; Jinfeng Li; Gaige Ye; Xianjing Zhang; Tengxiao Xu; Huaqing Li
Journal:  BMC Infect Dis       Date:  2022-01-19       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.